| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.09B | +5.0% |
| Cost of Revenue | $228.1M | -12.5% |
| Gross Profit | $862.0M | +10.9% |
| R&D Expense | $264.9M | +6.5% |
| SG&A Expense | $137.4M | +6.5% |
| Operating Income | $79.6M | +56.9% |
| Interest Expense | $6.1M | +58.2% |
| Pre-tax Income | $85.2M | +36.1% |
| Income Tax | -$159.5M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $624.6M | +62.8% |
| Short-term Investments | $98.2M | +1.3% |
| Accounts Receivable | $292.7M | +4.0% |
| Current Assets | $1.10B | +30.3% |
| Total Assets | $1.67B | +34.4% |
| Current Liabilities | $922.1M | +35.7% |
| Long-term Debt | $448.6M | +21.0% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $332.3M | +4.2% |
| Capital Expenditures | $2.6M | -45.3% |
| Investing Cash Flow | -$23.2M | +72.0% |
| Financing Cash Flow | -$62.4M | +77.1% |
| Free Cash Flow | $329.7M | +5.0% |
| -140.0% |
| Net Income | $244.6M | +89.6% |
| EPS (Basic) | $1.40 | +102.9% |
| EPS (Diluted) | $1.36 | +103.0% |
| Total Liabilities |
| $1.47B |
| +24.6% |
| Stockholders' Equity | -$297.0M | +31.1% |